W. Abraham

发表

Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination

D. Irvine, Heikyung Suh, Jamal Elkhader, 2013, Science Translational Medicine.

Vaccine delivery with microneedle skin patches in nonhuman primates

D. Irvine, Heikyung Suh, P. Hammond, 2013, Nature Biotechnology.

Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor

D. Irvine, Sudha Kumari, K. Wittrup, 2019, Science.

Engineered immunogen binding to alum adjuvant enhances humoral immunity

Daniel W. Kulp, D. Irvine, D. Burton, 2020, Nature Medicine.

Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2

Neil C. Dalvie, J. C. Love, Sergio A. Rodriguez-Aponte, 2021, Science advances.

The Injury Response to DNA Damage Promotes Anti-Tumor Immunity

D. Irvine, M. Yaffe, Lauren E. Milling, 2020, bioRxiv.

A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity

D. Irvine, D. Burton, A. Belcher, 2021, Science Immunology.

Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability

Rebecca L. Holden, D. Irvine, Mark R. Karver, 2018, Cancer Immunology Research.

Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells

D. Irvine, Chensu Wang, K. Rakhra, 2021, Science Immunology.

Eradication of tumors with pre-existing antigenic heterogeneity by vaccine-mediated co-engagement of CAR T and endogenous T-cells

J. C. Love, D. Irvine, C. A. Whittaker, 2022, bioRxiv.

Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.

Darrell J Irvine, Ellis L Reinherz, D. Irvine, 2015, Vaccine.

Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells

D. Irvine, Yiran Zheng, Bonnie Huang, 2015, Science Translational Medicine.

Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.

Gregory L. Szeto, D. Irvine, M. Hanson, 2015, The Journal of clinical investigation.

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

Ryan L. Kelly, D. Lauffenburger, D. Irvine, 2016, Nature Medicine.

The injury response to DNA damage in live tumor cells promotes antitumor immunity

Brian A. Joughin, D. Irvine, M. Yaffe, 2021, Science Signaling.

Low protease activity in B cell follicles promotes retention of intact antigens after immunization

J. C. Love, N. Hacohen, D. Irvine, 2023, Science.

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization

D. Irvine, Q. Sattentau, D. Burton, 2021, Science Advances.

Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity

Daniel W. Kulp, D. Irvine, D. Burton, 2020, Nature Medicine.

Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines

D. Irvine, Yizhou Dong, Yuebao Zhang, 2022, Journal of Controlled Release.

In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes.

Darrell J Irvine, Matthias T Stephan, D. Irvine, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Spatially regulated protease activity in lymph nodes renders B cell follicles a sanctuary for retention of intact antigens

N. Hacohen, D. Irvine, Heikyung Suh, 2021, bioRxiv.

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization

D. Irvine, Q. Sattentau, D. Burton, 2021, bioRxiv.

Engineered immunogen binding to alum adjuvant enhances humoral immunity

Daniel W. Kulp, D. Irvine, D. Burton, 2020, Nature Medicine.

Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR

D. Irvine, Aereas Aung, M. Melo, 2023, Nature Biomedical Engineering.

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

J. C. Love, D. Irvine, Heikyung Suh, 2023, Cell.

Design of Cytotoxic T Cell Epitopes by Machine Learning of Human Degrons

D. Irvine, D. Keskin, Catherine J. Wu, 2023, bioRxiv.

Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides.

D. Irvine, E. Reinherz, Mikyung Kim, 2015, Vaccine.

Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability

Rebecca L. Holden, D. Irvine, Mark R. Karver, 2018, Cancer Immunology Research.

Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination

D. Irvine, Heikyung Suh, Jamal Elkhader, 2013, Science Translational Medicine.

Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells

Heikyung Suh, S. Grupp, K. Wittrup, 2024, bioRxiv.

Design of Cytotoxic T Cell Epitopes by Machine Learning of Human Degrons

Nicholas L. Truex, W. Abraham, Na Li, 2024, ACS central science.

Design of Cytotoxic T Cell Epitopes by Machine Learning of Human Degrons

D. Irvine, D. Keskin, Catherine J. Wu, 2023, bioRxiv.